Skip to content
10-Q

Quarterly Report

Guardant Health, Inc. GH

0001576280-25-000277

← back to feed
Filed
Oct 29, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Oct 24, 2025 126.04M sh
Shares Diluted Q3 2025 · Sep 30, 2025 124.81M sh
Shares Diluted Q3 2025 · Sep 30, 2025 124.27M sh
Shares Diluted Q3 2025 · Sep 30, 2024 123.05M sh
Shares Diluted Q3 2025 · Sep 30, 2024 122.41M sh
Stock Repurchased Q3 2025 · Sep 30, 2025 $45.01M
Stock Repurchased Q3 2025 · Sep 30, 2024 $0
Capex Q3 2025 · Sep 30, 2025 $20.46M
Capex Q3 2025 · Sep 30, 2024 $16.21M
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$158.39M
Operating Cash Flow Q3 2025 · Sep 30, 2024 −$175.35M
Long Term Debt Q3 2025 · Sep 30, 2025 $1.11B
Long Term Debt Q3 2025 · Dec 31, 2024 $1.14B
Cash And Equivalents Q3 2025 · Sep 30, 2025 $580.01M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $525.54M
Cash And Equivalents Q3 2025 · Sep 30, 2024 $585.02M
Stockholders Equity Q3 2025 · Sep 30, 2025 −$354.47M
Stockholders Equity Q3 2025 · Jun 30, 2025 −$305.48M
Stockholders Equity Q3 2025 · Dec 31, 2024 −$139.65M
Stockholders Equity Q3 2025 · Sep 30, 2024 −$60.1M
Stockholders Equity Q3 2025 · Jun 30, 2024 −$1.61M
Stockholders Equity Q3 2025 · Dec 31, 2023 $158.68M
Current Liabilities Q3 2025 · Sep 30, 2025 $236.92M
Current Liabilities Q3 2025 · Dec 31, 2024 $225.58M
Total Liabilities Q3 2025 · Sep 30, 2025 $1.63B
Total Liabilities Q3 2025 · Dec 31, 2024 $1.63B
Current Assets Q3 2025 · Sep 30, 2025 $828.89M
Current Assets Q3 2025 · Dec 31, 2024 $1.06B
Total Assets Q3 2025 · Sep 30, 2025 $1.28B
Total Assets Q3 2025 · Dec 31, 2024 $1.49B
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.74
Eps Diluted Q3 2025 · Sep 30, 2025 −$2.32
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.88
Eps Diluted Q3 2025 · Sep 30, 2024 −$2.66
Eps Basic Q3 2025 · Sep 30, 2025 −$0.74
Eps Basic Q3 2025 · Sep 30, 2025 −$2.32
Eps Basic Q3 2025 · Sep 30, 2024 −$0.88
Eps Basic Q3 2025 · Sep 30, 2024 −$2.66
Sga Expense Q3 2025 · Sep 30, 2025 $53.27M
Sga Expense Q3 2025 · Sep 30, 2025 $150.48M
Sga Expense Q3 2025 · Sep 30, 2024 $49.13M
Sga Expense Q3 2025 · Sep 30, 2024 $128.24M
Rd Expense Q3 2025 · Sep 30, 2025 $89.96M
Rd Expense Q3 2025 · Sep 30, 2025 $265.93M
Rd Expense Q3 2025 · Sep 30, 2024 $87.31M
Rd Expense Q3 2025 · Sep 30, 2024 $254.21M
Net Income Q3 2025 · Sep 30, 2025 −$92.73M
Net Income Q3 2025 · Sep 30, 2025 −$287.78M
Net Income Q3 2025 · Sep 30, 2024 −$107.75M
Net Income Q3 2025 · Sep 30, 2024 −$325.37M
Operating Income Q3 2025 · Sep 30, 2025 −$98.99M
Operating Income Q3 2025 · Sep 30, 2025 −$316.44M
Operating Income Q3 2025 · Sep 30, 2024 −$117.33M
Operating Income Q3 2025 · Sep 30, 2024 −$317.63M
Cost Of Revenue Q3 2025 · Sep 30, 2025 $93.59M
Cost Of Revenue Q3 2025 · Sep 30, 2025 $249.52M
Cost Of Revenue Q3 2025 · Sep 30, 2024 $74.49M
Cost Of Revenue Q3 2025 · Sep 30, 2024 $212.21M
Revenue Q3 2025 · Sep 30, 2025 $265.2M
Revenue Q3 2025 · Sep 30, 2025 $700.76M
Revenue Q3 2025 · Sep 30, 2024 $191.48M
Revenue Q3 2025 · Sep 30, 2024 $537.2M